Germline deletion of AMP‐activated protein kinase β subunits reduces bone mass without altering osteoclast differentiation or function
J Quinn(The University of Melbourne), Bryce J. W. van Denderen(St Vincent's Hospital Melbourne), John W. Scott(Seattle University), Bruce E. Kemp(The University of Melbourne), Shanna Tam(St Vincent's Hospital Melbourne), Natalie A. Sims(The University of Melbourne), Hasnawati Saleh(Hasanuddin University), Ingrid J. Poulton(St Vincents Institute of Medical Research), Narelle E. McGregor(St. Vincent's Medical Center), Matthew T. Gillespie(Hudson Institute of Medical Research)
Cited by 62
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase
|Diabetes|2006|893
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
|FEBS Letters|1999|832
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536